Nanobiotix (NBTX) Debt Ratio (2018 - 2025)
Nanobiotix (NBTX) posted Debt Ratio of 1.41 for Q4 2025, up 86.31% on a QoQ basis from 0.76 in Q4 2024, and up 86.31% year-over-year from 0.76 in Q4 2024.
Nanobiotix (NBTX) has 8 years of Debt Ratio data on file, last reported at 1.41 in Q4 2025.
- In Q4 2025, Debt Ratio rose 86.31% year-over-year to 1.41; the TTM figure through Dec 2025 stood at 0.35 (up 128.46% YoY), while the FY2025 annual figure was 1.41, up 86.31% from the prior year.
- Debt Ratio grew to 1.41 in Q4 2025, from 0.76 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.41 in Q4 2025 and bottomed at 0.45 in Q4 2021.
- A 5-year average of 0.74 and a median of 0.54 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio climbed 0.4% — and 2025, when it soared 86.31%.
- Year by year, Debt Ratio stood at 0.45 in 2021, then gained by 18.62% to 0.54 in 2022, then grew by 0.4% to 0.54 in 2023, then surged by 40.21% to 0.76 in 2024, then surged by 86.31% to 1.41 in 2025.
- The last three Debt Ratio figures came in at 1.41 (Q4 2025), 0.76 (Q4 2024), and 0.54 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.41 |
| Jun 30, 2025 | 1.13 |
| Dec 31, 2024 | 0.76 |
| Jun 30, 2024 | 0.57 |
| Dec 31, 2023 | 0.54 |
| Jun 30, 2023 | 1.34 |
| Dec 31, 2022 | 0.54 |
| Jun 30, 2022 | 0.56 |
| Dec 31, 2021 | 0.45 |
| Jun 30, 2021 | 0.41 |
| Dec 31, 2020 | 0.37 |
| Dec 31, 2019 | 0.79 |
| Dec 31, 2018 | 0.44 |